PCM
BMY icon

Princeton Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Princeton Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,187
Closed -$257K – 121
2024
Q2 		$257K Sell
6,187
-805
-12% -$36K 0.08% 83
2024
Q1 		$379K Sell
6,992
-668
-9% -$34K 0.14% 72
2023
Q4 		$393K Sell
7,660
-1,172
-13% -$61.5K 0.16% 67
2023
Q3 		$513K Sell
8,832
-2,426
-22% -$149K 0.24% 58
2023
Q2 		$720K Sell
11,258
-848
-7% -$56.9K 0.3% 53
2023
Q1 		$839K Sell
12,106
-28,560
-70% -$2.01M 0.36% 52
2022
Q4 		$2.93M Sell
40,666
-5,415
-12% -$408K 1.3% 25
2022
Q3 		$3.28M Sell
46,081
-738
-2% -$53.5K 1.43% 23
2022
Q2 		$3.6M Sell
46,819
-17,175
-27% -$1.31M 1.4% 22
2022
Q1 		$4.67M Buy
63,994
+106
+0.2% +$7.12K 1.45% 18
2021
Q4 		$3.98M Sell
63,888
-1,265
-2% -$74.2K 1.14% 26
2021
Q3 		$3.85M Sell
65,153
-452
-0.7% -$29.8K 1.23% 25
2021
Q2 		$4.38M Buy
65,605
+332
+0.5% +$21.6K 1.36% 23
2021
Q1 		$4.12M Sell
65,273
-1,252
-2% -$77.9K 1.39% 24
2020
Q4 		$4.13M Buy
66,525
+2,997
+5% +$184K 1.48% 20
2020
Q3 		$3.83M Buy
63,528
+2,184
+4% +$131K 1.54% 21
2020
Q2 		$3.61M Buy
61,344
+1,870
+3% +$112K 1.6% 21
2020
Q1 		$3.64M Buy
59,474
+2,413
+4% +$147K 1.89% 18
2019
Q4 		$3.78M Buy
57,061
+139
+0.2% +$7.96K 1.69% 22
2019
Q3 		$2.89M Sell
56,922
-888
-2% -$41.7K 1.4% 24
2019
Q2 		$2.62M Sell
57,810
-2,582
-4% -$120K 1.28% 26
2019
Q1 		$2.88M Buy
60,392
+1,425
+2% +$71K 1.45% 23
2018
Q4 		$3.06M Sell
58,967
-32,227
-35% -$1.73M 1.79% 20
2018
Q3 		$5.66M Sell
91,194
-28,545
-24% -$1.69M 2.35% 15
2018
Q2 		$6.63M Sell
119,739
-1,166
-1% -$63K 2.88% 11
2018
Q1 		$7.65M Sell
120,905
-7,405
-6% -$476K 3.4% 8
2017
Q4 		$7.86M Buy
+128,310
New +$8.03M 3.52% 8

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Princeton Capital Management's BMY Position: Q3 2024 in Review

Princeton Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 6,187 shares — an estimated $257K sold.

Princeton Capital Management first reported a position in BMY in Q4 2017 and held it in 27 quarters. The position peaked at $7.86M in Q4 2017. 2,263 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Princeton Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • Princeton Capital Management sold 6,187 Bristol-Myers Squibb shares in Q3 2024, an estimated $257K.
  • Princeton Capital Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 27 quarters.
  • Princeton Capital Management's Bristol-Myers Squibb position peaked at $7.86M in Q4 2017.
  • 2,263 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Princeton Capital Management's 13F filing for Q3 2024, filed 7 Nov 2024.